Willital G H, Heine H
Clinic and Polyclinic for Surgery of Children, Westphalian Wilhelm University, Münster, Germany.
Int J Clin Pharmacol Res. 1994;14(5-6):193-202.
Scar development was investigated in 45 young patients who had undergone thoracic surgery. Patients were randomly assigned either to a group which was treated topically with Contractubex gel (Merz + Co., D-Frankfurt/Main), containing 10% onion extract, 50/U of sodium heparin per one g of gel and 1% allantoin, or to a group receiving no treatment. The treatment began on average 26 days after the operation and was continued for one year. The scars of all treated and untreated patients were evaluated at monthly intervals. The appearance of the scar, including scar type and scar size as well as scar colour, was assessed by the physician. A reduction of the increase of scar width was seen in the Contractubex-treated group as compared with the untreated group. Further, physiological scars and skin-coloured scars were more frequent in the treated group than in the untreated group. Hypertrophic or keloidal scars were less frequent in the treated group. No differences in scar length and scar height were seen. At the end of the observation period, the clinical course of scar development was rated as "very good" or "good" in more than 90% of the treated patients, "good" in less than 40% and "moderate" or "bad" in more than 60% of the untreated cases. The tolerability of the drug was "good" or "very good" in all cases. In conclusion, Contractubex gel is useful in scar treatment after thoracic surgery.
对45例接受胸外科手术的年轻患者的瘢痕形成情况进行了研究。患者被随机分为两组,一组局部使用康瑞保凝胶(默克公司,德国美因河畔法兰克福)治疗,该凝胶每克含10%洋葱提取物、50单位肝素钠和1%尿囊素;另一组不接受治疗。治疗平均在术后26天开始,持续一年。每月对所有接受治疗和未接受治疗患者的瘢痕进行评估。由医生评估瘢痕的外观,包括瘢痕类型、瘢痕大小以及瘢痕颜色。与未治疗组相比,康瑞保治疗组瘢痕宽度增加量减少。此外,治疗组生理性瘢痕和肤色瘢痕比未治疗组更常见。治疗组肥厚性或瘢痕疙瘩性瘢痕较少见。瘢痕长度和瘢痕高度未见差异。在观察期结束时,超过90%接受治疗的患者瘢痕发展的临床过程被评为“非常好”或“好”,未治疗病例中不到40%被评为“好”,超过60%被评为“中等”或“差”。该药物在所有病例中的耐受性为“好”或“非常好”。总之,康瑞保凝胶对胸外科手术后的瘢痕治疗有效。